Page de couverture de The Line

The Line

The Line

Auteur(s): Matt Gurney and Jen Gerson
Écouter gratuitement

The Line is a Canadian magazine dedicated to covering local, national and international politics, news, current events and occasionally some obscure stories. Hosted by Matt Gurney and Jen Gerson.

© 2026 The Line
Politique
Épisodes
  • Is Alberta hurtling toward the edge?
    Aug 11 2026

    In this episode of On The Line, host Jen Gerson sits down with Jared Wesley and Ken Boessenkool, two members of the Lead Not Leave initiative, for a conversation about the current state of Alberta separatism and the province’s uncertain political future.

    This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit. This summer, BioCanRx and The Line have been talking about potential solutions for the problems that are limiting Canada’s ability to domestically develop new drugs, especially immunotherapies for cancer. We ask a lot of Canadian cancer researchers. The work required to discover new therapies for numerous diseases, and get them to patients, costs far more than the half-billion dollars invested in cancer research by all levels of government and charities –– and often the available grants specialize in only one part of the spectrum: discovery. We need to be sure we're supporting researchers at every step of this complex scientific and regulatory process. BioCanRx has proved you can meaningfully support this part. The entire team is only 12 people, but they know what it takes to do things like submit a clinical trial application or safely manufacture a drug, so the researchers they fund are held to firm, realistic standards that make sense in the real world of Canadian health-care systems and industry. That’s how a tiny not-for-profit has helped bring 16 new drugs to clinical trials that have treated more than 400 people in just 10 years. But research is only one part of the puzzle — can we manufacture new therapies in Canada? More on that next time. Visit BioCanRx.com to learn more.

    While recent polling has suggested that support for outright separation may be softer than some headlines imply, neither Wesley nor Boessenkool is particularly sanguine about the outcome of the coming referendum campaign. They argue that low turnout and voter suppression could produce a result that overstates support for separatism, creating a misleading picture of where Albertans actually stand.

    The discussion also examines the changing relationship between Alberta and Ottawa, and whether recent improvements between the provincial and federal governments have meaningfully reduced the political grievances that have fuelled separatist sentiment. They explore the concept of moral hazard in Canadian federalism, the incentives facing provincial leaders, and whether those dynamics are helping—or hurting—the cause of national unity.

    This episode is also brought to you by the Forest Products Association of Canada. Canada’s resilience will not be built through diversified trade and good intentions alone. It will be built with strong domestic supply chains, reliable Canadian materials, and industries that invest in workers and communities here at home.Two months ago, the federal government acknowledged the Forest Sector Transformation Task Force Report and the practical path it set out. Now the focus must be action. Canada’s forest products sector can help deliver the homes, infrastructure, and economic potential the country needs. But that requires predictable access to manage our forests, transportation systems that work, and a regulatory environment that rewards investment rather than delays it. The direction is clear. Now Ottawa needs to turn recognition into results.Learn more at FPAC.ca.

    Finally, Gerson asks what happens after the vote. Whatever the result, will the United Conservative Party be able to hold together, or are the internal tensions that have defined Alberta conservatism for years becoming too great to contain?

    As always, check out our main page at ReadTheLine.ca — and never, ever forget to like and subscribe!

    This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.


    #OnTheLine #Alberta #AlbertaPolitics #Separatism #LeadNotLeave #JaredWesley #KenBoessenkool #CanadaPolitics #JenGerson #TheLinePodcast

    Voir plus Voir moins
    56 min
  • How many times can Carney concede to Trump? (Probably lots)
    Aug 7 2026

    In the latest episode of The Line Podcast, recorded on August 7th, 2026, Matt Gurney is joined by guest host Scott Stinson, filling in for Jen Gerson. They begin with the latest twists in Canada-U.S. relations, asking just how much Prime Minister Mark Carney can concede to the Americans before the political costs become too high at home. Both hosts suspect the answer is probably more than many Canadians would expect. They also discuss how fortunate Carney is to be making these decisions while facing relatively weak opposition, with Pierre Poilievre enduring another difficult week. Matt explains why the Conservative leader continues to struggle to gain traction.

    This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.

    To larn more, visit ap1000.cameco.com.

    The conversation then shifts to Ontario politics, where many of the same themes are playing out. It should be a quiet summer at Queen’s Park, but instead the Ford government finds itself taking hits from all directions, including from an opposition party that doesn’t currently have a permanent leader. Matt and Scott discuss why the Ontario NDP appears so adrift. New Democratic governments are commonplace elsewhere in Canada, so why does the party remain unable to break through in Ontario, even with Doug Ford leading the PCs and the Liberals still searching for direction? Matt has a theory.

    This episode is also brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.

    Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.

    Find them Fractional-Execs.ca.

    Finally, Scott brings listeners up to speed on the growing controversy surrounding Gianni Infantino and FIFA. The discussion broadens into a look at why major sports organizations seem almost inevitably to attract corruption—and why it’s so fascinating to watch the rare moments when those organizations actually decide to push back.

    This episode is also brought to you by BioCanRx, a Canadian not-for-profit working to help Canadian researchers and companies develop new drugs, especially immunotherapies for cancer.

    A key challenge for Canada will be familiar to anyone trying to grow a business here: we have some of the brightest people in the world, we just can’t keep enough of them. Canada is home to researchers making breakthrough discoveries every day. But bringing a new therapy from the lab to patients takes more than great science. It also requires specialists who know how to manufacture complex products, navigate regulatory approval, and help new treatments be integrated into the health-care system. Too often, that expertise leaves Canada before the work is done.

    BioCanRx has supported hands-on training for more than 900 trainees over the past decade, but without a strong domestic industry, retention becomes a challenge. So how do we keep these highly-skilled people? Next time we’ll talk about how changing what we incentivize can maximize the impact of research money Canada already spends to sustain more drug development here in Canada. For now, go to BioCanRx.com to learn more.

    All that and more in the latest episode of The Line Podcast.

    CHAPTERS
    00:00 Intro
    01:37 Can Carney keep conceding? (Yup!)
    26:39 Fall of Ford
    48:34 FIFA WTF

    #TheLinePodcast
    #MarkCarney
    #CanadianPolitics
    #CanadaUSRelations
    #PierrePoilievre
    #DougFord
    #OntarioPolitics
    #FIFA
    #GianniInfantino
    #CurrentAffairs

    Voir plus Voir moins
    1 h et 7 min
  • How to fix the West's ammunition shortage
    Aug 4 2026
    In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about two of the West's most pressing security challenges: military readiness and cyber defence.This episode is brought to you by BioCanRx, a Canadian not-for-profit working to help Canadian researchers and companies develop new drugs, especially immunotherapies for cancer.A key challenge for Canada will be familiar to anyone trying to grow a business here: we have some of the brightest people in the world, we just can’t keep enough of them. Canada is home to researchers making breakthrough discoveries every day. But bringing a new therapy from the lab to patients takes more than great science. It also requires specialists who know how to manufacture complex products, navigate regulatory approval, and help new treatments be integrated into the health-care system. Too often, that expertise leaves Canada before the work is done.BioCanRx has supported hands-on training for more than 900 trainees over the past decade, but without a strong domestic industry, retention becomes a challenge. So how do we keep these highly-skilled people? Next time we’ll talk about how changing what we incentivize can maximize the impact of research money Canada already spends to sustain more drug development here in Canada. For now, go to BioCanRx.com to learn more.First up is Mark Cancian of the Center for Strategic and International Studies, a retired U.S. Marine Corps colonel and one of the authors of a new report examining the alarming state of Western ammunition stockpiles. Drawing on the lessons of the wars in Ukraine and the Persian Gulf, Cancian explains how the United States and its allies are consuming critical munitions far faster than they can replace them. The West still possesses enormous military strength, but rebuilding industrial capacity has become an urgent strategic priority. Matt and Mark discuss what's driving the shortages, what governments are finally getting right, and why there are at least a few encouraging signs that production is beginning to catch up.This episode is also brought to you by the Forest Products Association of Canada. Canada’s resilience will not be built through diversified trade and good intentions alone. It will be built with strong domestic supply chains, reliable Canadian materials, and industries that invest in workers and communities here at home. Two months ago, the federal government acknowledged the Forest Sector Transformation Task Force Report and the practical path it set out. Now the focus must be action. Canada’s forest products sector can help deliver the homes, infrastructure, and economic potential the country needs. But that requires predictable access to manage our forests, transportation systems that work, and a regulatory environment that rewards investment rather than delays it. The direction is clear. Now Ottawa needs to turn recognition into results. Learn more at FPAC.ca.Then Matt is joined by David Shipley of Beauceron Security to discuss a coordinated cyberattack that recently struck a series of public utilities across the United States, causing real disruption to critical infrastructure. They examine who may have been behind the attacks, why utilities remain such attractive targets, and what governments and operators can do to improve their defences. The conversation also turns to whether growing political dysfunction in Washington is making it harder for the United States—and by extension its allies—to respond effectively to increasingly sophisticated cyber threats.It's a pair of conversations about resilience, preparedness, and the growing realization that winning future conflicts will depend as much on industrial capacity and digital security as on military hardware alone.This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers. To learn more, visit ap1000.cameco.com.As always, check out our main page at ReadTheLine.ca, and don't forget to like and subscribe.#OnTheLine #MarkCancian #DavidShipley #CyberSecurity #NationalSecurity #Defense #Military #CSIS #CriticalInfrastructure #MattGurney
    Voir plus Voir moins
    1 h et 7 min
adbl_web_anon_alc_button_suppression_t1
Pas encore de commentaire